Literature DB >> 9617895

The Raf-1 protein mediates insulin-like growth factor-induced proliferation of erythroid progenitor cells.

M R Sanders1, H Lu, F Walker, S Sorba, N Dainiak.   

Abstract

Previous studies from this and other laboratories have shown that insulin-like growth factor-1 (IGF-I) and insulin-like growth factor-2 (IGF-II) support erythroid colony formation in cultures supplemented with serum substitute and recombinant erythropoietin. Subpopulations of IGF-I- and IGF-II-dependent, erythropoietin-independent colony-forming unit-erythroid (CFU-E)-derived colonies and BFU-E-derived colonies were identified under serum-substituted conditions for adult bone-marrow-derived erythroid progenitors which proliferate in the absence and presence of exogenous anti-erythropoietin receptor monoclonal antibody and in serum-substituted medium that was preadsorbed with anti-erythropoietin IgG. To assess whether Raf-1 is required for the formation of IGF-dependent, erythropoietin-independent human erythroid colonies, 5-15 microM sense or antisense oligomer to raf-1 were added to serum-substituted cultures containing either 2 U/ml recombinant human erythropoietin (rHuEpo) alone or 0-1,000 ng/ml IGF-I or IGF-II with/without 2 U/ml rHuEpo. Both erythropoietin-induced and IGF-induced erythroid colony formation were completely blocked by antisense (but not sense) oligomers to raf-1. Purified human CFU-Es were examined for Raf-1 message and protein. Total RNA was extracted, and raf-1 mRNA was detected on Northern blots. Furthermore, a 74 kD protein, corresponding to Raf-1, was also detected in CFU-Es purified from human adult sources. Together, these studies support the hypothesis that the Raf-1 protein mediates both erythropoietin-induced and IGF-induced signal transduction in human erythroid progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617895     DOI: 10.1002/stem.160200

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  5 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Insulin-like growth factor 1 mitigates hematopoietic toxicity after lethal total body irradiation.

Authors:  Dunhua Zhou; Divino Deoliveira; Yubin Kang; Seung S Choi; Zhiguo Li; Nelson J Chao; Benny J Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-25       Impact factor: 7.038

3.  Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.

Authors:  M Mikula; M Schreiber; Z Husak; L Kucerova; J Rüth; R Wieser; K Zatloukal; H Beug; E F Wagner; M Baccarini
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

Review 4.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

5.  Raf-1 antagonizes erythroid differentiation by restraining caspase activation.

Authors:  Andrea Kolbus; Sandra Pilat; Zvenyslava Husak; Eva Maria Deiner; Gabriele Stengl; Hartmut Beug; Manuela Baccarini
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.